Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8218050 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 9 Pages |
Abstract
Using moderate doses, SBRT for central lung tumors achieves acceptable local control with low rates of severe toxicity. Dosimetric analysis showed no significant correlation between dose to the lungs, heart, or NFZ and severe pulmonary toxicity. Esophageal toxicity may be an underappreciated risk, particularly when PTV overlaps the esophagus.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ankit MD, Andreas MD, Eric PhD, Amanda MS, Mihir BS, Weiji MS, Zhigang PhD, Daphna Y. MD, Kenneth E. MD, Ellen D. PhD, Andrew PhD, Abraham J. MD,